Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (ATGGF)
OTHER OTC:ATGGF
Total Valuation
Actinogen Medical has a market cap or net worth of $55.03M. The enterprise value is $50.36M.
Market Cap$55.03M
Enterprise Value$50.36M
Share Statistics
Actinogen Medical has 3,177,147,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,177,147,200
Owned by Insiders6.71%
Owned by Institutions―
Financial Efficiency
Actinogen Medical ’s return on equity (ROE) is -0.66 and return on invested capital (ROIC) is -36.42%.
Return on Equity (ROE)-0.66
Return on Assets (ROA)-0.61
Return on Invested Capital (ROIC)-36.42%
Return on Capital Employed (ROCE)-0.64
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.47
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical is -10.83. Actinogen Medical ’s PEG ratio is -2.06.
PE Ratio-10.83
PS Ratio0.00
PB Ratio7.18
Price to Fair Value7.18
Price to FCF-8.33
Price to Operating Cash Flow-8.34
PEG Ratio-2.06
Income Statement
In the last 12 months, Actinogen Medical had revenue of 9.93M and earned -13.04M in profits. Earnings per share was -0.01.
Revenue9.93M
Gross Profit9.93M
Operating Income-12.84M
Pretax Income-22.98M
Net Income-13.04M
EBITDA-12.92M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -8.72M and capital expenditures -9.03K, giving a free cash flow of -8.73M billion.
Operating Cash Flow-8.72M
Free Cash Flow-8.73M
Free Cash Flow per Share>-0.01
Dividends & Yields
Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)0.74
Average Volume (3m)833.00
Important Dates
Actinogen Medical upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 24, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Actinogen Medical as a current ratio of 13.91, with Debt / Equity ratio of 1.21%
Current Ratio13.91
Quick Ratio13.91
Debt to Market Cap0.00
Net Debt to EBITDA0.71
Interest Coverage Ratio-528.53
Taxes
In the past 12 months, Actinogen Medical has paid -9.93M in taxes.
Income Tax-9.93M
Effective Tax Rate0.43
Enterprise Valuation
Actinogen Medical EV to EBITDA ratio is -10.23, with an EV/FCF ratio of -7.80.
EV to Sales13.31
EV to EBITDA-10.23
EV to Free Cash Flow-7.80
EV to Operating Cash Flow-7.80
Balance Sheet
Actinogen Medical has $22.87M in cash and marketable securities with AU$289.64K in debt, giving a net cash position of -$22.58M billion.
Cash & Marketable Securities$22.87M
Total DebtAU$289.64K
Net Cash-$22.58M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 100.00%, with operating margin of -129.28%, and net profit margin of -131.34%.
Gross Margin100.00%
Operating Margin-129.28%
Pretax Margin-231.34%
Net Profit Margin-131.34%
EBITDA Margin-130.10%
EBIT Margin-133.47%
Analyst Forecast
The average price target for Actinogen Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―